Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Income	$ (74,286)	$ 103,135	$ 86,870
Depreciation and amortization	235,151	89,698	85,631
Amortization of Inventory Step-up	26,519	0	0
Operating Lease, Right-of-Use Asset, Amortization Expense	23,651	9,594	9,216
Provision for doubtful accounts	1,036	345	7,137
Provision for warranty and returns	4,902	831	(1,576)
Stock compensation	36,025	27,341	23,954
Gain (Loss) on Disposition of Property Plant Equipment	2,010	1,652	(1,789)
Gain (Loss) on Disposition of Business	374	0	0
Bond premium amortization	264	655	231
Debt issuance cost amortization	6,972	240	288
Change in fair value of contingent earn-out	(32,091)	0	9,000
Production Related Impairments or Charges	0	3,380	2,626
Sparepartsusage	11,924	13,046	11,191
Other	(103)	2,582	6,939
Increase (Decrease) in Accounts Receivable	(19,151)	13,755	78,049
Increase (Decrease) in Inventories	(201,095)	20,815	19,196
Increase (Decrease) in Prepaid Expense and Other Assets	22,903	(7,973)	(4,311)
Increase (Decrease) in Other Operating Assets	(21,290)	(21,038)	(16,069)
Accounts payable	37,472	2,347	(46,415)
Accrued liabilities	(55,834)	6,259	(29,379)
Income taxes, including excess tax benefits and deferred income taxes	(66,734)	874	(18,037)
Net cash provided by operating activities	(62,129)	267,538	222,752
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property and equipment	(90,311)	(68,542)	(92,005)
Proceeds from Sale of Other Property, Plant, and Equipment	989	218	6,176
Intangible asset additions	(9,018)	(12,627)	(8,385)
Business acquisitions, net of cash acquired	(1,844,164)	(14,452)	0
Payments to Acquire Equity Method Investments	0	(3,250)	0
Purchases of investment securities	(3,397)	(10,034)	(32,825)
Proceeds from sale of investment securities	36,433	18,000	28,900
Net cash (used in) provided by investing activities	(1,909,468)	(90,687)	(98,139)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of long-term debt, net of lender debt issuance costs	1,664,362	0	0
Repayments of Long-term obligations	(22,375)	0	0
Payments of Debt Issuance Costs	(2,177)	0	0
Proceeds from Long-term Lines of Credit	0	0	150,000
Repayments of Short-Term Debt	0	0	150,000
Proceeds from exercise of stock options	8,785	9,372	13,193
Finance Lease, Principal Payments	(680)	(607)	(357)
Payment for Contingent Consideration Liability, Financing Activities	0	(17,300)	0
Purchase of treasury stock	(10,883)	(8,335)	(12,876)
Net cash (used in) provided by financing activities	1,637,032	(16,870)	(40)
Effect of Exchange Rate on Cash [Abstract]
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations	(9,478)	(3,251)	2,854
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Total	(344,043)	156,730	127,427
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents	208,784	552,827	396,097
SUPPLEMENTAL DISCLSOURE OF CASH FLOW INFORMATION
Cash paid during the year for income taxes	27,504	19,562	31,628
Interest Paid, Excluding Capitalized Interest, Operating Activities	63,713	858	1,753
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING ACTIVITIES
Accounts payable for property and equipment	4,854	9,338	2,211
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable		0
Smiths Medical
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING ACTIVITIES
Fair value of assets acquired	1,606,300
Cash paid for acquisitions, net of cash acquired	(1,844,164)
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable	(575,975)
Contingent consideration	(55,158)
Goodwill, Period Increase (Decrease)	1,462,752
Liabilities Assumed	593,755
International Distributor
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING ACTIVITIES
Noncash Non-compete agreement with associated contingent earn-out liability	$ 0	2,589	$ 0
Foreign Infusion System Supplier
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING ACTIVITIES
Fair value of assets acquired		4,592
Cash paid for acquisitions, net of cash acquired		(14,452)
Contingent consideration		0
Goodwill, Period Increase (Decrease)		10,626
Liabilities Assumed		$ 766